• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.11% Nasdaq Up0.41%

    AllianzGI Health Sciences D (DGHCX)

    35.16 Down 0.69(1.92%) Nov 12

    Profile as of Oct 30, 2015Get Profile for:
    AllianzGI Health Sciences D
    Allianz Funds1345 Avenue of the AmericasNew York, NY 10105
    Map
    Phone: 800-498-5413
    Fund Overview 
    Category:Health
    Fund Family:Allianz Funds
    Net Assets:208.13M
    Year-to-Date Return:10.97%
    Yield:0.00%
    Morningstar Rating:3 stars
    Fund Inception Date:Dec 31, 1996
    Morningstar Style Box 
    Health
    [View Category Definition]
    View Top Health Funds
    About the Morningstar Style Box
    Management Information 
    John R. Schroer
    Lead Manager since Jan 13, 2014
    Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. Mr. Schroer has more than 20 years of investment-industry experience. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. an M.B.A. in finance from the University of Wisconsin.
    Investment Information 
    Min Initial Investment:1,000
    Min Initial Investment, IRA:1,000
    Min Initial Investment, AIP:1,000
    Min Subsequent Investment:50
    Min Subsequent Investment, IRA:50
    Min Subsequent Investment, AIP:50
    DGHCX can be purchased from 71 brokerages.

    Fund Summary 
    The investment seeks long-term capital appreciation. The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio managers consider health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences or that otherwise promote healthy living. The fund will invest primarily in common stocks and other equity securities.

    Fund Operations 
    Last Dividend : 0.00
    Last Cap Gain (Dec 10, 2014) : 0.00
    Annual Holdings Turnover (Nov 11, 2015) : 76.00%
    Average for Category:43.99%
    Fees & Expenses 
    ExpenseDGHCXCategory Avg
    Annual Report Expense Ratio (net):1.46%1.32%
    Prospectus Net Expense Ratio:1.46%N/A
    Prospectus Gross Expense Ratio:1.46%N/A
    Max 12b1 Fee:0.25%N/A
    Max Front End Sales Load:N/A5.30%
    Max Deferred Sales Load: N/A2.31%
    3 Yr Expense Projection*:462594
    5 Yr Expense Projection*:797862
    10 Yr Expense Projection*:1,7461,702
    * Per $10,000 invested